CRIS Current Research Information System

DAJTI, ELTON
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.451
NA - Nord America 7.116
EU - Europa 3.369
AF - Africa 406
SA - Sud America 380
Continente sconosciuto - Info sul continente non disponibili 351
OC - Oceania 8
Totale 19.081
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.924
VN - Vietnam 2.041
SG - Singapore 1.805
CN - Cina 1.739
IT - Italia 1.327
HK - Hong Kong 491
DE - Germania 366
BD - Bangladesh 362
KR - Corea 295
GB - Regno Unito 285
BR - Brasile 281
SE - Svezia 275
IN - India 254
NL - Olanda 220
FR - Francia 171
JP - Giappone 141
IE - Irlanda 128
FI - Finlandia 103
CI - Costa d'Avorio 101
ZA - Sudafrica 100
CA - Canada 90
RU - Federazione Russa 88
SC - Seychelles 80
CH - Svizzera 68
ES - Italia 64
ID - Indonesia 56
AT - Austria 45
PH - Filippine 45
BG - Bulgaria 44
TG - Togo 42
MX - Messico 40
TR - Turchia 39
TH - Thailandia 38
NG - Nigeria 36
UA - Ucraina 32
PL - Polonia 31
AR - Argentina 29
EC - Ecuador 25
PK - Pakistan 25
BE - Belgio 23
JO - Giordania 20
TW - Taiwan 20
IQ - Iraq 19
CR - Costa Rica 17
JM - Giamaica 14
EG - Egitto 13
GR - Grecia 12
PT - Portogallo 12
VE - Venezuela 12
CO - Colombia 11
LT - Lituania 11
AL - Albania 10
EE - Estonia 10
SA - Arabia Saudita 9
AU - Australia 8
CL - Cile 8
CZ - Repubblica Ceca 8
KE - Kenya 8
HR - Croazia 6
IR - Iran 6
PE - Perù 6
RO - Romania 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
RS - Serbia 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
LB - Libano 4
MA - Marocco 4
MK - Macedonia 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
BB - Barbados 3
BO - Bolivia 3
NI - Nicaragua 3
SV - El Salvador 3
TN - Tunisia 3
AO - Angola 2
CM - Camerun 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
GD - Grenada 2
GH - Ghana 2
GT - Guatemala 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
LV - Lettonia 2
MD - Moldavia 2
MM - Myanmar 2
MT - Malta 2
OM - Oman 2
SN - Senegal 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
Totale 18.708
Salva come PNG Salva come JPEG
Città #
Singapore 1.315
Ashburn 715
Hefei 591
Ho Chi Minh City 531
Hanoi 467
San Jose 457
Hong Kong 437
Fairfield 435
Bologna 311
Seoul 268
Chandler 253
New York 236
Los Angeles 210
Dallas 193
Santa Clara 189
Southend 185
Council Bluffs 179
Boardman 177
Beijing 164
Milan 133
Dublin 125
Tokyo 105
Abidjan 101
Rome 100
Da Nang 96
Houston 90
Seattle 90
Lauterbourg 82
Princeton 82
Haiphong 74
Johannesburg 74
Wilmington 70
Atlanta 69
Cambridge 69
Munich 67
Woodbridge 66
São Paulo 65
Buffalo 61
Bern 56
Bengaluru 55
Helsinki 55
Frankfurt am Main 54
Turin 48
San Francisco 47
Dong Ket 44
Chicago 42
Lomé 42
Sofia 42
Amsterdam 40
Redondo Beach 40
Florence 37
Phoenix 36
Redmond 36
Barcelona 34
Abeokuta 33
Orem 33
Shanghai 32
Bremen 31
Guangzhou 31
Boydton 29
Brooklyn 29
Denver 29
Ann Arbor 27
Hải Dương 27
Montreal 27
North Bergen 27
Vienna 27
Berlin 26
Biên Hòa 26
Naples 26
Turku 25
Bến Tre 24
Des Moines 24
London 24
Nanjing 23
San Diego 23
Warsaw 23
Paris 22
Washington 22
Jakarta 21
Lappeenranta 21
Piscataway 21
Amman 20
Brussels 20
Bắc Ninh 20
Palermo 20
Tongling 20
Hyderabad 19
Rimini 19
Secaucus 19
Vũng Tàu 19
The Dalles 18
Chennai 17
Mexico City 17
Newark 17
Tianjin 17
Falkenstein 16
Hangzhou 16
Quận Ba 16
Thái Bình 16
Totale 10.699
Salva come PNG Salva come JPEG
Nome #
Autoimmune Atrophic Gastritis: A Clinical Review 940
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure 587
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis 434
Monofocal hepatocellular carcinoma: How much does size matter? 302
A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease 279
Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: An Updated Meta-analysis and Meta-regression 278
Burden of gastric cancer attributable to Helicobacter pylori in 27 countries from seven geographic regions in 2022 251
Recalibrating survival prediction among patients receiving trans‐arterial chemoembolization for hepatocellular carcinoma 249
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programs 246
Pattern of macrovascular invasion in hepatocellular carcinoma 246
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 243
Assessment of liver stiffness measurement and ultrasound findings change during inotuzumab ozogamicin cycles for relapsed or refractory acute lymphoblastic leukemia 242
Utility of Doppler-Ultrasound and Liver Elastography in the Evaluation of Patients with Suspected Pregnancy-Related Liver Disease 238
Sarcopenia evaluated by EASL/AASLD computed tomography-based criteria predicts mortality in patients with cirrhosis: A systematic review and meta-analysis 236
Sarcopenia predicts ascitic decompensation and mortality independently of portal hypertension status in patients with advanced chronic liver disease outside the liver transplantation setting 234
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter study 228
The changing scenario of hepatocellular carcinoma in Italy: an update 227
Clinical impact of sarcopenia assessment in patients with hepatocellular carcinoma undergoing treatments 225
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 222
Clinical impact of sarcopenia assessment in patients with liver cirrhosis 214
Pre-transplant psoas muscle density as a ready-to-use and low-cost predictor of patient survival after liver transplant 208
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 207
Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis 205
Diagnostic Approach to Elevated Liver Function Tests during Pregnancy: A Pragmatic Narrative Review 200
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 199
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 195
Advances in Endo-Hepatology: The Role of Endoscopic Ultrasound in the Management of Portal Hypertension 195
A SPLEEN STIFFNESS MEASUREMENT-BASED MODEL FOR THE RECOGNITION OF HIGH RISK VARICES: BAVENO VI CRITERIA AND BEYOND 193
“Are the Expanded Baveno VI Criteria really safe to screen compensated cirrhotic patients for high-risk varices?” 189
The non‐invasive evaluation of liver involvement in patients with cystic fibrosis: A prospective study 185
Standard Bismuth Quadruple Therapy versus Concomitant Therapy for the First-Line Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 183
Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease 178
A spleen stiffness measurement-based model for the recognition of high risk varices: Baveno VI criteria and beyond 178
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 178
Segmental Distribution of Hepatocellular Carcinoma in Cirrhotic Livers 177
Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder 176
Adherence to European Society of Gastrointestinal Endoscopy Quality Performance Measures for Upper and Lower Gastrointestinal Endoscopy: A Nationwide Survey From the Italian Society of Digestive Endoscopy 176
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 175
The Role of Microbiota in Upper Gastrointestinal Cancers 171
Role of imaging techniques in liver veno-occlusive disease diagnosis: recent advances and literature review 170
Non-invasive tests for the prediction of post-hepatectomy liver failure in the elderly 170
Porto-sinusoidal vascular disorder in surgical candidates for liver metastases: prevalence, non-invasive diagnosis, and burden on surgical outcomes 168
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 166
Hierarchically Positioning Laparoscopic Microwave Ablation in the Therapeutic Span of Early Hepatocellular Carcinoma: A Real-Life Comparative Analysis 164
Outcome of hepatic resection for HCC in ideal and non-ideal candidates 161
Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis 158
Sarcopenia predict complications after hepatic resection for primary hepatocellular carcinoma (HCC) in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH) 155
The interplay between sarcopenia and portal hypertension predicts ascites and mortality in cirrhosis: Sarcopenia predicts ascites and death in cirrhotic patients 155
Approaches to the Diagnosis of Portal Hypertension: Non-Invasive or Invasive Tests? 155
Corrigendum: Adherence to European society of gastrointestinal endoscopy quality performance measures for upper and lower gastrointestinal endoscopy: a nationwide survey from the Italian society of digestive endoscopy 153
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases 152
New practice guidelines on risk stratification and management of portal hypertension: towards a personalized multidisciplinary approach 150
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 150
Spleen stiffness measurement predicts the development of primary hepatocellular carcinoma better than hepatic venous pressure gradient 149
Non-invasive diagnosis of clinically significant portal hypertension and treatment with non-selective beta-blockers: a new paradigm 148
Is Ultrasound Elastography Useful in Predicting Clinically Relevant Pancreatic Fistula After Pancreatic Resection?: A Systematic Review and Meta-analysis 147
Liver Measurement Stiffness Can Predict Chemotherapy-related Liver Injury and Complications after Surgery for Liver Metastases 146
Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED) 146
Liver and Spleen Stiffness Measurements for Assessment of Portal Hypertension Severity in Patients with Budd Chiari Syndrome 146
Minimally invasive hepatectomy vs. thermoablation for single small (≤3 cm) hepatocellular carcinoma: A weighted real-life national comparison 145
Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: A review of the literature 145
Idiopathic chronic intestinal pseudo-obstruction syndrome is strongly associated with low serum levels of vitamin D 144
Clinical presentation of celiac disease and diagnosis accuracy in a single-center european pediatric cohort over 10 years 143
Osteosarcopenia in NAFLD/MAFLD: An Underappreciated Clinical Problem in Chronic Liver Disease 142
Predictive factors for hepatocellular carcinoma recurrence after curative treatments 140
A spleen stiffness measurement-based model for recognition of high risk varices: Baveno VI criteria and beyond 139
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 137
Non-invasive tests for the prediction of primary hepatocellular carcinoma 135
Adherence to international guidelines for the management of Helicobacter pylori infection among gastroenterologists and gastroenterology fellows in Italy: A Survey of the Italian Federation of Digestive Diseases - FISMAD 134
New insights on portal hypertension's screening in people with cystic fibrosis 130
Gut microbiota signatures and clinical manifestations in celiac disease children at onset: a pilot study 129
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients- UEG Week 2020 Poster Presentations 125
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis 124
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 124
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival 123
Hepatic encephalopathy and MELD-Na predict treatment benefit in autoimmune hepatitis-related decompensated cirrhosis 120
Prediction of posthepatectomy liver failure: Role of SSM and LSPS 120
Antibiotic use during gastrointestinal infections increases the risk of developing irritable bowel syndrome: a Systematic Review and Meta-Analysis 118
Validation of a standardized CT protocol for the evaluation of varices and porto-systemic shunts in cirrhotic patients 115
null 115
Incidence and clinical significance of recompensation after HCV-cure 114
Spleen stiffness measurement for assessing the response to β-blockers therapy for high-risk esophageal varices patients 113
A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease 112
LBP-034-YI Genetic characterization of adult-onset cryptogenic cholestasis: a prospective multicentre study of 233 patients 111
Risk of hepatocellular carcinoma after HCV eradication: Determining the role of portal hypertension by measuring spleen stiffness 109
In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score 108
The role of liver and spleen elastography in advanced chronic liver disease 107
Size and location of spontaneous portosystemic shunts predict the risk of decompensation in cirrhotic patients 105
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure 103
Antibiotic prophylaxis in patients with cirrhosis: Current evidence for clinical practice 102
Ruolo e significato clinico dei metodi non invasivi nella valutazione dell’ipertensione portale nel paziente affetto da epatopatia cronica 101
Reply to: Triple-phase CT scan for disease progression prediction in cirrhosis: A valid repurpose? 101
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 100
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysis 100
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study 99
Sarcopenia Predicts Major Complications after Resection for Primary Hepatocellular Carcinoma in Compensated Cirrhosis 98
Covid-19 in a young liver transplant recipient: Caution for drug-drug interactions 95
Recurrence rate, features, and outcome after hepatocellular carcinoma curative resection or ablation according to the IMbrave050 criteria: a real-world study 94
Efficacy and safety of endoscopic ultrasound-guided hepaticogastrostomy: a meta-regression analysis 93
Trial sequential analysis of EUS-guided gallbladder drainage versus percutaneous cholecystostomy in patients with acute cholecystitis 93
Totale 17.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.200
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.200
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.109 0 14 25 31 80 34 42 69 53 71 550 140
2022/20231.384 76 136 52 160 107 127 60 55 248 45 169 149
2023/2024667 41 94 58 65 58 167 27 34 25 44 31 23
2024/20252.713 108 245 209 194 261 129 238 111 60 288 283 587
2025/20269.939 821 1.025 770 713 664 334 1.479 409 1.667 696 642 719
2026/20272.230 1.318 912 0 0 0 0 0 0 0 0 0 0
Totale 19.081